Synbiotics Corp.

News & Analysis

synbiotics corp. - All News and Analysis

• Daou, Synbiotics Forced to Delist From Nasdaq

  - 2001-05-07

  Finance: Firms Tend to Downplay Significance as Impacts Hard to Pinpoint While companies downplay its significance, getting delisted from a major stock exchange like the Nasdaq is something they try to avoid. Recently, two San Diego firms were delisted from Nasdaq, when the shares of both firms dropped...

  Tags: FINANCE, Investment, Nasdaq Stock Market Inc., stock, Synbiotics Corp.

• Synbiotics Corporation Receives Nasdaq Notification; Company Files Request for Hearing on Nasdaq Decision; Delisting Action Halted Pending Panel Decision On Appeal

  - 2001-04-11

  Business Editors & Health/Medical Writers SAN DIEGO--BW HealthWire--April 11, 2001 Synbiotics Corp. (Nasdaq:SBIO) today announced that it has filed an appeal with Nasdaq to rescind the decision to delist the Company from The Nasdaq National Market. Nasdaq has confirmed that the request for a hearing suspends the...

  Tags: Company, FINANCE, Manufacturing, Nasdaq Stock Market Inc., Synbiotics Corp.

• Synbiotics Corporation Announces Approval of Witness Canine Heartworm Test

  - 1998-07-28

  SAN DIEGO--BUSINESS WIRE--July 28, 1998--Synbiotics Corporation (NASDAQ:SBIO) announced today that it has obtained U.S. Department of Agriculture approval to market WitnessrHW in the United States, the fastest and easiest to use product yet developed for the diagnosis of canine heartworm.WitnessrHW represents the latest Synbiotics innovation in easy-to-use diagnostic products for...

  Tags: Business Wire, Company, HEALTHCARE, SALES, SECURITY, Synbiotics Corp., U.S., virus, Witness

• Synbiotics Corp. signs agreement to acquire International Canine Genetics Inc

  - 1996-07-25

  SAN DIEGO--BUSINESS WIRE--July 25, 1996--Synbiotics Corp. (NASDAQ:SBIO) and Malvern, Pa.-based International Canine Genetics Inc. (OTC Bulletin Board:ICGI;ICGIW), Thursday announced they have signed a definitive agreement under which International Canine Genetics ICG will be acquired by Synbiotics.The acquisition is subject to certain regulatory and stockholder approvals.Under the terms of the agreement,...

  Tags: acquisition, agreement, Benefits, Business Wire, FINANCE, HEALTHCARE, Investment, SOFTWARE, Synbiotics Corp.

• Synbiotics Corp. initiates employee benefits for veterinary care

  - 1996-07-02

  SAN DIEGO--BUSINESS WIRE--July 2, 1996--Synbiotics Corp. (NASDAQ:SBIO) Tuesday announced that the company is initiating an employee-benefit program to assist with covering the cost of veterinary care for employees' pets.Under this program, employees will be reimbursed for pet care provided by a licensed veterinarian.``Our business is developing, manufacturing and marketing animal...

  Tags: Benefits, Business Wire, HEALTHCARE, SOFTWARE, Synbiotics Corp., vaccine

• Synbiotics Corp. receives USDA approval for room temperature storage of ICT GOLD HW diagnostic; new storage saves time, money and shelf space

  - 1996-05-02

  SAN DIEGO--BUSINESS WIRE--May 2, 1996--Synbiotics Corp. (NASDAQ:SBIO) Thursday announced that it has received USDA approval for room temperature storage of its leading diagnostic test, ICT GOLD HW, for canine heartworm diagnosis.The new approval gives Synbiotics the first heartworm diagnostic test that can be stored at room temperature without affecting the...

  Tags: HARDWARE, Storage, Strategy, Synbiotics Corp., U.S. Department of Agriculture

• Synbiotics Corp. introduces new canine parvo virus diagnostic test; simplified format offers speed and accuracy

  - 1996-05-02

  SAN DIEGO--BUSINESS WIRE--May 2, 1996--Synbiotics Corp. (NASDAQ:SBIO) Thursday announced that the company is introducing a new diagnostic product for the detection of canine parvo virus.ASSURE/PARVO offers clinicians a simple and rapid method for performing in-clinic parvo virus testing.The 10-minute colorimetric test is conducted by simply resuspending canine fecal samples in...

  Tags: Business Wire, clinician, SECURITY, Synbiotics Corp., virus

• Synbiotics Corp. reports results for fiscal 1995; ICT GOLD HW diagnostic test drives revenue growth

  - 1996-03-29

  SAN DIEGO--BUSINESS WIRE--March 29, 1996--Synbiotics Corp. (NASDAQ:SBIO) Friday reported revenues of $14.1 million for the year ended Dec. 31, 1995 versus $12.1 million for the prior 12 month period, an increase of 17%.The company also reported net income of $501,000 or 9 cents per share for 1995, compared to a...

  Tags: Business Wire, FINANCE, revenue, SALES, Strategy, Synbiotics Corp.

• Synbiotics Corp. to receive additional shares in Texas Biotechnology Corp

  - 1995-07-25

  SAN DIEGO--BUSINESS WIRE--July 25, 1995--Synbiotics Corp. (NASDAQ:SBIO) Tuesday reported that it will receive an additional 573,109 shares in Texas Biotechnology Corp. TBC, a Houston-based biopharmaceutical company.In July 1994, Synbiotics' then-41-percent-owned affiliate ImmunoPharmaceutics Inc. IPI was merged with TBC. Pursuant to the merger agreement, TBC announced Tuesday that IPI has...

  Tags: Business Wire, contingency, FINANCE, Houston, Investment, merger, Synbiotics Corp.

• Synbiotics Corp. receives USDA license for ICT heartworm diagnostic test; accurate, fast, user-friendly test format

  - 1995-03-22

  SAN DIEGO--BUSINESS WIRE--March 22, 1995--Synbiotics Corp. (NASDAQ:SBIO) Wednesday announced that it has received a USDA license for its new state-of-the-art ICT canine heartworm diagnostic test.Synbiotics will immediately begin marketing its ICT heartworm test to the $16.5 million U.S. in-clinic stat canine heartworm diagnostic market.The Synbiotics test is a folding cardlike...

  Tags: Strategy, Synbiotics Corp., U.S. Department of Agriculture